Cramer's Investing Club Stock Profile: Drugmaker Abbvie deserves a lot more love from the market

As we wait for the market to gain more appreciation for Abbvie, the roughly 4.15% dividend handsomely pays us for our patience.

from Health and Science https://ift.tt/3Iyct7F
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH